eXciteOSA is a FDA approved DAYtime treatment for patients suffering from primary snoring or mild obstructive sleep apnea (OSA). This device, an intra-oral neuromuscular stimulator, is used 20 minutes per day for 6 weeks followed by twice a week resulting in significant reduction in OSA and snoring scores.

In a study of 65 mild obstructive sleep apnea patients, 79% of patients responded to therapy with a mean reduction of 52% in AHI (Apnea Hypopnea Index), a 50% reduction in ODI (Oxygen Desaturation Index), and a 3.9 point reduction in ESS (Epworth Sleepiness Scale).

Made by Signifier Medical Technologies, this device can be purchased with a doctor's prescription at: [ Ссылка ]

For more information on this device: [ Ссылка ]

Check out our online snoring store: [ Ссылка ]

Anatomy (0:10)
eXciteOSA Device (1:05)

More info on OSA:
[ Ссылка ]

Animation reproduced with permission from Signifier Medical Technologies.

No money received for this product placement.

This video produced by Dr. Chris Chang:
[ Ссылка ]

Still haven’t subscribed to Fauquier ENT on YouTube? ►► [ Ссылка ]

References:
• Wu J, et al. Short-term electrical stimulation alters tongue muscle fibre type composition. Archives or Oral Biology 2007;52(6):544-551.
• Whitfang J, et al. First results on daytime submandibular electrostimulation of suprahyoidal muscles to prevent night-time hypopharyngeal collapse in obstructive sleep apnea syndrome. International Journal of Oral and Maxillofacial surgery. 1999;28(1):21-5.
• White DP. Sleep-related breathing disorder: 2—pathophysiology of obstructive sleep apnoea. Thorax. 1995; 50:797–804. (PubMed: 7570420)
• Wessolleck E, Bernd E, Dockter S, et al. Intraoral electrical muscle stimulation in the treatment of snoring. Somnologie. 2018; 22 (Suppl 2): 47–52.
• Sama A, et al. Daytime Intraoral Neurostimulation with eXciteOSA for Treatment of Snoring and Mild Sleep Apnea. CHEST Annual Meeting Notes. 2018.

#osa #sleepapnea #snoring #exciteosa #apnea #medicalanimation

свернуть